摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

16-epi-19-oxokopsinine

中文名称
——
中文别名
——
英文名称
16-epi-19-oxokopsinine
英文别名
methyl (1R,9R,16R,18S,21R)-20-oxo-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate
16-epi-19-oxokopsinine化学式
CAS
——
化学式
C21H24N2O3
mdl
——
分子量
352.433
InChiKey
VYUCPRSICORYAG-NKXUHPISSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    26
  • 可旋转键数:
    2
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.62
  • 拓扑面积:
    58.6
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    16-epi-19-oxokopsinine吡啶18-冠醚-6potassium tert-butylate氧气二异丁基氢化铝 作用下, 以 四氢呋喃乙醇正己烷叔丁醇 为溶剂, 反应 8.0h, 生成 16-epi-11,12-demethoxy-N-demethoxycarbonyl-16-deoxypauciflorine B p-toluenesulfonamide
    参考文献:
    名称:
    kopsijasminilam和deoxykopsijasminilam的生物遗传合成。
    摘要:
    由外消旋的米诺霉素(6)的环化衍生而来的六环酮酸酯7被还原为两种C-19差向异构醇8和9。相应O磺酰基衍生物的立体电子控制裂解分别提供了六环烯胺14和氧化后的烯烃16,具有桥头双键的五环内酰胺17。形成氨基甲酸酯,在C-16处引入第二个双键,并在C-20处进行共轭还原羟基化或氢化,得到标题产物。
    DOI:
    10.1021/jo000398h
  • 作为产物:
    描述:
    (+/-)-minovincine盐酸 作用下, 以 甲醇 为溶剂, 反应 24.0h, 以44%的产率得到16-epi-19-oxokopsinine
    参考文献:
    名称:
    kopsijasminilam和deoxykopsijasminilam的生物遗传合成。
    摘要:
    由外消旋的米诺霉素(6)的环化衍生而来的六环酮酸酯7被还原为两种C-19差向异构醇8和9。相应O磺酰基衍生物的立体电子控制裂解分别提供了六环烯胺14和氧化后的烯烃16,具有桥头双键的五环内酰胺17。形成氨基甲酸酯,在C-16处引入第二个双键,并在C-20处进行共轭还原羟基化或氢化,得到标题产物。
    DOI:
    10.1021/jo000398h
点击查看最新优质反应信息

文献信息

  • A Biomimetic Synthesis of the Pauciflorine A and B Skeleton
    作者:Martin E. Kuehne、Yun-Long Li
    DOI:10.1021/ol9910215
    日期:1999.12.1
    [GRAPHICS]Racemic minovincine (3), following cyclization, reduction, O-tosylation, fragmentation, and carbamate formation, provided the deoxypauciflorine 12.
  • Biogenetic Syntheses of Kopsijasminilam and Deoxykopsijasminilam
    作者:Martin E. Kuehne、Yun-Long Li、Chang-Qing Wei
    DOI:10.1021/jo000398h
    日期:2000.10.1
    derived from cyclization of racemic minovincine (6), was reduced to two C-19 epimeric alcohols 8 and 9. Stereoelectronically controlled fragmentations of corresponding O-sulfonyl derivatives provided, respectively, the hexacyclic enamine 14 and, after oxidation of the olefin 16, the pentacyclic lactam 17 with a brigehead double bond. Formation of a carbamate, introduction of a second double bond at
    由外消旋的米诺霉素(6)的环化衍生而来的六环酮酸酯7被还原为两种C-19差向异构醇8和9。相应O磺酰基衍生物的立体电子控制裂解分别提供了六环烯胺14和氧化后的烯烃16,具有桥头双键的五环内酰胺17。形成氨基甲酸酯,在C-16处引入第二个双键,并在C-20处进行共轭还原羟基化或氢化,得到标题产物。
查看更多

同类化合物

蕊木宁F 蕊木宁 柯蒲木酮碱 夾竹桃鹼 (3aR,5R,5aR,10bR,13aS)-6-甲酰基-2,3,4,5,11,12-六氢-6H,13ah-3a,5a-乙桥-1H-吲哚嗪并[8,1-cd]咔唑-5-羧酸甲酯 (2a,3b,5a,6a,7a,20S)-6,7-环氧-20-羟基-白坚木替宁-3-羧酸甲酯 (2R,5S)-6alpha,7alpha-环氧白坚木替宁-3beta-羧酸甲酯 (2R,5R)-6,7-二去氢白坚木替宁-3beta-羧酸甲酯 16-epi-19-oxokopsinine methyl carbamate (+/-)-16-epi-19-R-mesyloxykopsinine 16-epi-19-oxokopsinine (+/-)-16-epi-19-R-hydroxykopsinine (-)-Norpleiomutine 16,17-Didehydro-5-oxo-18-(phenylsulfonyl)aspidofractinine N(1)-methyl-14,15-didehydroaspidofractinine Aspidofractinine-3-carboxylic acid, methyl ester, (2alpha,3beta,5alpha)- Methyl 1-formyl-17-methoxyaspidofractinine-21-carboxylate methyl (1R,9R,16R,18R,21S)-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7,14-tetraene-18-carboxylate N(a),3β-Dimethoxycarbonyl-aspidofraktinin (+/-)-aspidofractinine aspidofractinin-4(or 20)-one 17-oxoaspidofractinine (+/-)-N-methyl-aspidofractinine Kopsinylalkohol aspidofractinine N1-acetylcopsinine methyl (1S,2R,4S,9R,17R,18R,22R)-3-oxa-6,16-diazaheptacyclo[15.2.2.11,6.02,4.09,17.010,15.09,22]docosa-10,12,14-triene-18-carboxylate methyl (1R,9R,16S,18R,21S)-6-[(15R,17R,19S)-15-(1-hydroxyethyl)-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraen-17-yl]-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3(8),4,6-triene-18-carboxylate 5-oxoaspidofractinine methyl (1S,9R,16R,18R,21S)-2-acetyl-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate methyl (1S,9R,16S,18R,21S)-2-acetyl-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate (1S,9S,16R,18S,21S)-2-methoxycarbonyl-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylic acid (1S,9R,16R,18S,21S)-2-methoxycarbonyl-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylic acid methyl (1R,9R,16S,18S,21R)-2-formyl-4-methoxy-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3(8),4,6-triene-18-carboxylate methyl (1S,9R,16R,18S,21S)-11-oxo-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate methyl (1S,9R,16R,18S,21S)-12-methyl-2-aza-12-azoniahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate methyl (1S,9S,16S,18S,21S)-12-methyl-2-aza-12-azoniahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate dimethyl (1S,9R,16R,18S,21S)-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-2,18-dicarboxylate methyl (1S,9R,16R,18R,21S)-12-ethyl-2-aza-12-azoniahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate methyl (1S,9R,16R,18S,21S)-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate methyl (1R,4R,12R,13S,16S)-17-oxo-5,14-diazahexacyclo[12.4.3.01,13.04,12.06,11.012,16]henicosa-6,8,10-triene-4-carboxylate methyl (1R,4R,12R,13S,16R)-17-oxo-5,14-diazahexacyclo[12.4.3.01,13.04,12.06,11.012,16]henicosa-6,8,10-triene-4-carboxylate methyl (1R,9R,12S,16R,18R,21R)-12-methyl-2-aza-12-azoniahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate methyl (1S,9R,16S,18S,21R)-2-formyl-4-methoxy-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3(8),4,6-triene-18-carboxylate Kopsan methyl (1S,9S,16S,18R,21R)-2-acetyl-12-methyl-2-aza-12-azoniahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate dimethyl (1S,9R,16S,18S,21S)-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-2,18-dicarboxylate methyl (1S,9S,16S,18S,21R)-2-formyl-4-methoxy-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3(8),4,6-triene-18-carboxylate methyl (1S,9R,16S,18R,21S)-12-methyl-2-aza-12-azoniahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate methyl (1R,9S,16R,18R,21S)-2,12-diazahexacyclo[14.2.2.19,12.01,9.03,8.016,21]henicosa-3,5,7-triene-18-carboxylate